Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Impairment of lecithin:cholesterol acyltransferase (LCAT) activity in hemodialyzed subjects. I. No evidence of plasma LCAT-inhibiting factors.

Impairment of lecithin:cholesterol acyltransferase (LCAT) activity in hemodialyzed subjects. I. No evidence of plasma LCAT-inhibiting factors. Panminerva Med. 1984 Apr-Jun; 26(2):97-100.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.